Effect of probiotic fermented milk (Kefir) on glycemic control and lipid profile in type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial

Iranian Journal of Public Health

Volumn 44, Issue 2, 2015, Pages 228-237

  Ostadrahimi, Alireza ^a   Taghizadeh, Akbar ^b   Mobasseri, Majid ^c   Farrin, Nazila ^a   Payahoo, Laleh ^a   Beyramalipoor Gheshlaghi, Zahra ^b   Vahedjabbari, Morteza ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TABRIZ   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes; Glucose; Kefir; Lipid profile; Probiotic fermented milk

Indexed keywords

EID: 84934890780     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Leahy JL(2005). Pathogenesis of type 2 diabetes mellitus. Arch Med Res, 36(3):197-209.
2. Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, et al. (2008). Prevalence of Diabetes and Impaired Fasting Glucose in the Adult Population of Iran National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care, 31(1):96-98.
3. Guarner F, Perdigon G, Corthier Gr, Salminen S, Koletzko B, Morelli L (2005). Should yoghurt cultures be considered probiotic? Br J Nutr, 93(6):783-86.
4. Lye H-S, Kuan C-Y, Ewe J-A, Fung W-Y, Liong M-T(2009). The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens. Int J Mol Sci, 10(9):3755-75.
5. Davari S, Talaei SA, Alaei H (2013). Probiotics treatment improves diabetesinduced impairment of synaptic activity and cognitive function: behavioral and electrophysiological proofs for microbiomegutbrain axis. Neuroscience, Epub Mar 7.
6. Zhang Y, Wang L, Zhang J, Li Y, He Q, Li H, et al. (2013). Probiotic Lactobacillus casei Zhang ameliorates highfructoseinduced impaired glucose tolerance in hyperinsulinemia rats. Eur J Nutr, Epub ahead of print.
7. Yun SI, Park HO, Kang JH (2009). Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. J Appl Microbiol, 107(5):1681-86.
8. Greenfield JR, Campbell LV(2006). Relationship Between Inflammation, Insulin Resistance and Type 2 Diabetes: Cause or Effect? Curr Diabetes Rev.2(2):195-211.
9. Lin M-Y, Chen T-W(2000). Reduction of cholesterol by Lactobacillus acidophilus in culture broth. J Food Drug Anal, 8(2):97-102.
10. Kumar R, Grover S, Batish VK (2011). Hypocholesterolaemic effect of dietary inclusion of two putative probiotic bile salt hydrolaseproducing Lactobacillus plantarum strains in Sprague-Dawley rats. British J Nutr, 105(4):561-573.
11. Kumar M, Nagpal R, Kumar R, Hemalatha R, Verma V, Kumar A, et al(2012). Cholesterollowering probiotics as potential biotherapeutics for metabolic diseases.Exp Diabetes Res, 2012:902917.
12. Ooi L-G, Liong M-T(2010). Cholesterollowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int J Mol Sci, 11(6):2499-2522.
13. Musso G, Gambino R, Cassader M (2010). Obesity, Diabetes, and Gut Microbiota The hygiene hypothesis expanded? Diabetes Care, 33(10):2277-84.
14. Mazloom Z, Yousefinejad A, Dabbaghmanesh MH(2013). Effect of Probiotics on Lipid Profile, Glycemic Control, Insulin Action, Oxidative Stress, and Inflammatory Markers in Patients with Type 2 Diabetes: A Clinical Trial. Iran J Med Sci, 38(1):38-43.
15. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V, et al (2011). Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J Dairy Sci, 94(7):3288-94.
16. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V(2012). Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition, 28(5):539-543.
17. Moroti C, Magri LFS, de Rezende Costa M, Cavallini DCU, Sivieri K (2012). Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus. Lipids In Health And Disease,11.
18. Andreasen AS, Larsen N, Pedersen-Skovsgaard T, Berg RMG, Moller K, Svendsen KD, et al. (2010). Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr, 104(12):1831-1838.
19. Yadav H, Jain S, Sinha PR(2007). Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition, 23(1):62-68.
20. Lin C-H, Lin C-C, Shibu MA, Liu C-S, Kuo C-H, Tsai F-J, et al. (2014). Oral Lactobacillus reuteri GMN-32 treatment reduces blood glucose concentrations and promotes cardiac function in rats with streptozotocininduced diabetes mellitus. Br J Nutr, 111(4): 598-605.
21. Yun S, Park H, Kang J(2009). Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes.J Appl Microbiol, 107(5):1681-86.
22. Al-Salami H, Butt G, Fawcett JP, Tucker IG, Golocorbin-Kon S, Mikov M (2008). Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats. Eur J Drug Metab Pharmacokinet, 33(2):101-106.
23. Yamano T, Tanida M, Niijima A, Maeda K, Okumura N, Fukushima Y, et al. (2006). Effects of the probiotic strain Lactobacillus johnsonii strain La1 on autonomic nerves and blood glucose in rats. Life Sci, 79(20):1963-1967.
24. Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2003). Are oxidative stressactivated signaling pathways mediators of insulin resistance and betacell dysfunction?Diabetes, 52(1):1-8.
25. King GL, Loeken MR. (2004). Hyperglycemiainduced oxidative stress in diabetic complications. Histochem Cell Biol, 122(4):333-8.
26. Dunlop M (2000). Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney International,77.S3-S12.
27. Nishikawa T, Edelstein D, Du XL, Yamagishi S-i, Matsumura T, Kaneda Y, et al. (2000). Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 404(677):787-90.
28. Guo Z, Liu XM, Zhang QX, Shen Z, Tian FW, Zhang H, et al. (2011). Influence of consumption of probiotics on the plasma lipid profile: a metaanalysis of randomised controlled trials. Nutr Metab Cardiovasc Dis, 21(11):844-850.
29. Wang L-X, Liu K, Gao D-W, Hao J-K (2013). Protective effects of two Lactobacillus plantarumstrains in hyperlipidemic mice. World J Gastroenterol, 19(20):3150-56.
30. Sudha MR, Chauhan P, Dixit K, Babu S, Jamil K (2009). Probiotics as complementary therapy for hypercholesterolemia. Biology and Medicine, 1(4).
31. St-Onge M-P, Farnworth ER, Savard T, Chabot D, Mafu A, Jones PJH (2002). Kefir consumption does not alter plasma lipid levels or cholesterol fractional synthesis rates relative to milk in hyperlipidemic men: a randomized controlled trial [ISRCTN10820810]. BMC Complement Altern Med, 2:1.
32. Motawee MM, ElBehairy S, Suzan FIES, Abd El-All S. Effect of some probiotic strains on lipid metabolism. National organization for drug control and research (NODCAR)- Giza- Egypt.1-20.
33. Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, et al. (2007). Selective increases of bifidobacteria in gut microflora improve highfatdietinduced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia, 50(11):2374-2383.
34. Pickup JC (2004). Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care, 27(3):813-23.
35. Chiu Y-H, Lu Y-C, Ou C-C, Lin S-L, Tsai C-C, Huang C-T, et al. (2013). Lactobacillus plantarum MYL26 induces endotoxin tolerance phenotype in Caco-2 cells. BMC Microbiol, 13:190.
36. Calcinaro F, Dionisi S, Marinaro M, Candeloro P, Bonato V, Marzotti S, et al. (2005). Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the nonobese diabetic mouse. Diabetologia, 48(8):1565-75.